134 related articles for article (PubMed ID: 16244703)
21. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
[TBL] [Abstract][Full Text] [Related]
22. Critical roles of CD30/CD30L interactions in murine autoimmune diabetes.
Chakrabarty S; Nagata M; Yasuda H; Wen L; Nakayama M; Chowdhury SA; Yamada K; Jin Z; Kotani R; Moriyama H; Shimozato O; Yagita H; Yokono K
Clin Exp Immunol; 2003 Sep; 133(3):318-25. PubMed ID: 12930356
[TBL] [Abstract][Full Text] [Related]
23. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.
Kummer JA; Vermeer MH; Dukers D; Meijer CJ; Willemze R
J Invest Dermatol; 1997 Nov; 109(5):636-40. PubMed ID: 9347791
[TBL] [Abstract][Full Text] [Related]
24. Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30).
Sarker AB; Akagi T; Jeon HJ; Miyake K; Murakami I; Yoshino T; Takahashi K; Nose S
Am J Pathol; 1992 Jul; 141(1):19-23. PubMed ID: 1352944
[TBL] [Abstract][Full Text] [Related]
25. Expression and Clinical Significance of CD30 and CD56 in Lymphoblastic Lymphoma: A Retrospective Analysis on Paraffin-Embedded Tissues by Immunohistochemistry.
Li S; Zheng S; Huang X; Zhang W; Liu F; Cao Q
Fetal Pediatr Pathol; 2024; 43(2):111-122. PubMed ID: 38213180
[No Abstract] [Full Text] [Related]
26. CD30 antigen expression in florid immunoblastic proliferations. A clinicopathologic study of 14 cases.
Segal GH; Kjeldsberg CR; Smith GP; Perkins SL
Am J Clin Pathol; 1994 Sep; 102(3):292-8. PubMed ID: 8085551
[TBL] [Abstract][Full Text] [Related]
27. A monoclonal antibody, 3G12, reacts with a novel surface molecule, Hal-1, with high expression in CD30-positive anaplastic large cell lymphomas.
Asanuma H; Takahashi S; Ishikawa M; Kamiguchi K; Sato N; Poppema S; Fujimoto JI; Kikuchi K
Br J Haematol; 1999 Jul; 106(1):55-63. PubMed ID: 10444163
[TBL] [Abstract][Full Text] [Related]
28. 16-year experience at M. D. Anderson Cancer Center with primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large cell lymphoma.
Romaguera JE; Garcia-Foncillas J; Cabanillas F
Leuk Lymphoma; 1995 Dec; 20(1-2):97-102. PubMed ID: 8750629
[TBL] [Abstract][Full Text] [Related]
29. Using oligonucleotide aptamer probes for immunostaining of formalin-fixed and paraffin-embedded tissues.
Zeng Z; Zhang P; Zhao N; Sheehan AM; Tung CH; Chang CC; Zu Y
Mod Pathol; 2010 Dec; 23(12):1553-8. PubMed ID: 20693984
[TBL] [Abstract][Full Text] [Related]
30. Posttransplant CD30 (Ki-1)-positive anaplastic large cell lymphoma. Report of a case with presentation as a pleural effusion.
Jiménez-Heffernan JA; Viguer JM; Vicandi B; Jiménez-Yuste V; Palacios J; Escuin F; Gamallo C
Acta Cytol; 1997; 41(5):1519-24. PubMed ID: 9305394
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical evidence of abnormal expression of the antioncogene-encoded p53 phosphoprotein in Hodgkin's disease and CD30+ anaplastic lymphomas.
Doglioni C; Pelosio P; Mombello A; Scarpa A; Chilosi M
Hematol Pathol; 1991; 5(2):67-73. PubMed ID: 1680118
[TBL] [Abstract][Full Text] [Related]
32. Expression of Ki-1 antigen (CD30) in mesenchymal tumors.
Mechtersheimer G; Möller P
Cancer; 1990 Oct; 66(8):1732-7. PubMed ID: 2169996
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease.
Engert A; Burrows F; Jung W; Tazzari PL; Stein H; Pfreundschuh M; Diehl V; Thorpe P
Cancer Res; 1990 Jan; 50(1):84-8. PubMed ID: 2152774
[TBL] [Abstract][Full Text] [Related]
34. Tumor viruses in CD30-positive anaplastic large cell lymphomas.
Herbst H; Stein H
Leuk Lymphoma; 1993 Mar; 9(4-5):321-8. PubMed ID: 8394168
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the t(2;5) (p23;q35) translocation in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
Wood GS
Leuk Lymphoma; 1998 Mar; 29(1-2):93-101. PubMed ID: 9638979
[TBL] [Abstract][Full Text] [Related]
36. CD30 ligand expression in nonmalignant and Hodgkin's disease-involved lymphoid tissues.
Gruss HJ; Pinto A; Gloghini A; Wehnes E; Wright B; Boiani N; Aldinucci D; Gattei V; Zagonel V; Smith CA; Kadin ME; von Schilling C; Goodwin RG; Herrmann F; Carbone A
Am J Pathol; 1996 Aug; 149(2):469-81. PubMed ID: 8701986
[TBL] [Abstract][Full Text] [Related]
37. CD30/Ki-1-positive anaplastic large cell lymphoma preceded by Hodgkin's disease.
Tsurumi H; Takahashi T; Moriwaki H; Muto Y
Int J Hematol; 1992 Aug; 56(1):99-102. PubMed ID: 1327272
[TBL] [Abstract][Full Text] [Related]
38. Ki-1-positive anaplastic large cell lymphoma with different phenotypes in skin nodules and lymph nodes.
Oka K; Matsumoto T
Dermatology; 1994; 188(1):52-6. PubMed ID: 8305759
[TBL] [Abstract][Full Text] [Related]
39. Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes.
Ramos CA; Ballard B; Zhang H; Dakhova O; Gee AP; Mei Z; Bilgi M; Wu MF; Liu H; Grilley B; Bollard CM; Chang BH; Rooney CM; Brenner MK; Heslop HE; Dotti G; Savoldo B
J Clin Invest; 2017 Sep; 127(9):3462-3471. PubMed ID: 28805662
[TBL] [Abstract][Full Text] [Related]
40. Costimulatory molecules in the developing human gastrointestinal tract: a pathway for fetal allergen priming.
Jones CA; Vance GH; Power LL; Pender SL; Macdonald TT; Warner JO
J Allergy Clin Immunol; 2001 Aug; 108(2):235-41. PubMed ID: 11496240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
